Description
Studies have shown HSA to be an effective marker that may be used in a panel with CEA (Carcinoembryonic Antigen), CK7, AFP (Alpha Fetoprotein) and CD10 to aid in the differential diagnosis of hepatocellular carcinoma from cholangiocarcinoma and/or metastatic adenocarcinoma.
Specifications
| WEIGHT | N/A |
|---|---|
| DIMENSIONS | N/A |
| INTENDED USE | RUO |
| SPECIES REACTIVITY | Human |
| SOURCE | Mouse Monoclonal |
| CLONE | OCH1E5 |
| ISOTYPE | IgG1/kappa |
| ANTIGEN | Hepatocyte Specific Antigen |
| LOCALIZATION | Cytoplasmic |
| POSITIVE CONTROL | Liver or liver carcinoma |
